Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:29
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer
    Lu, Pamela W.
    Fields, Adam C.
    Yoo, James
    Irani, Jennifer
    Goldberg, Joel E.
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (08) : 1306 - 1313
  • [2] Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients
    Lino-Silva, Leonardo S.
    Anchondo-Nunez, Patricia
    Chit-Huerta, Alonso
    Aguilar-Romero, Estefania
    Morales-Soto, Jonathan
    Salazar-Garcia, Jenny A.
    Guzman-Lopez, Cristina J.
    Maldonado-Martinez, Hector A.
    Meneses-Garcia, Abelardo
    Salcedo-Hernandez, Rosa A.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 300 - 307
  • [3] Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
    Sotelo, M. J.
    Sastre, J.
    Maestro, M. L.
    Veganzones, S.
    Vieitez, J. M.
    Alonso, V.
    Gravalos, C.
    Escudero, P.
    Vera, R.
    Aranda, E.
    Garcia-Alfonso, P.
    Gallego-Plazas, J.
    Lopez, C.
    Pericay, C.
    Arrivi, A.
    Vicente, P.
    Ballesteros, P.
    Elez, E.
    Lopez-Ladron, A.
    Diaz-Rubio, E.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 535 - 541
  • [4] Impact of delay to surgery on survival in stage I-III colon cancer
    Grass, Fabian
    Behm, Kevin T.
    Duchalais, Emilie
    Crippa, Jacopo
    Spears, Grant M.
    Harmsen, William S.
    Hubner, Martin
    Mathis, Kellie L.
    Kelley, Scott R.
    Pemberton, John H.
    Dozois, Eric J.
    Larson, David W.
    EJSO, 2020, 46 (03): : 455 - 461
  • [5] Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection
    Uen, Yih-Huei
    Lu, Chien-Yu
    Tsai, Hsiang-Lin
    Yu, Fang-Jung
    Huang, Ming-Yii
    Cheng, Tian-Lu
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (08) : 2120 - 2128
  • [6] Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer
    Swords, Douglas S.
    Bednarski, Brian K.
    Messick, Craig A.
    Tillman, Matthew M.
    Chang, George J.
    You, Y. Nancy
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 706 - 716
  • [7] A robust gene signature for the prediction of early relapse in stage I-III colon cancer
    Dai, Weixing
    Li, Yaqi
    Mo, Shaobo
    Feng, Yang
    Zhang, Long
    Xu, Ye
    Li, Qingguo
    Cai, Guoxiang
    MOLECULAR ONCOLOGY, 2018, 12 (04) : 463 - 475
  • [8] Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer
    Zheng, Peilin
    Lai, Chen
    Yang, Weimin
    Guo, Jianping
    Xiao, Shihan
    Chen, Zhikang
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 202 - 208
  • [9] Comparison of survival of stage I-III colon cancer by travel distance and hospital volume
    Turner, M. C.
    Jawitz, O.
    Adam, M. A.
    Srinivasan, E.
    Niedzwiecki, D.
    Migaly, J.
    Fisher, D. A.
    Mantyh, C. R.
    TECHNIQUES IN COLOPROCTOLOGY, 2020, 24 (07) : 703 - 710
  • [10] Preoperative serum markers for individual patient prognosis in stage I-III colon cancer
    Giessen-Jung, Clemens
    Nagel, Dorothea
    Glas, Maria
    Spelsberg, Fritz
    Lau-Werner, Ulla
    Modest, Dominik Paul
    Schulz, Christoph
    Heinemann, Volker
    Di Gioia, Dorit
    Stieber, Petra
    TUMOR BIOLOGY, 2015, 36 (10) : 7897 - 7906